Aysegül Ilhan-Mutlu

17PUBLICATIONS
18CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 23, 2026
Therapeutic management of resectable mismatch-repair deficient/microsatellite instability-high gastroesophageal adenocarcinoma: a real-world analysis from Austria.

|Aug 29, 2025
Lack of association between prior or concurrent malignancies and overall survival in gastroesophageal cancer: evidence from a large European single-center cohort.

Hannah C Puhr, Luzia Berchtold, Linda Zingerle

|Aug 28, 2025
Lymphovascular Invasion (LVI) Correlates with Systemic Immune-Inflammation Index (SII) in Adenocarcinoma of the Gastroesophageal Junction (AEG): Implications for Prognostic Stratification.

Gerd Jomrich, Winny Yan, Dagmar Kollmann

|Feb 13, 2025
Current Landscape of Molecular Biomarkers in Gastroesophageal Tumors and Potential Strategies for Co-Expression Patterns.

Martin Korpan, Hannah Christina Puhr, Julia M Berger

|Nov 09, 2024
Overexpression of Fibroblast Growth Factor 8 Is a Predictor of Impaired Survival in Esophageal Squamous Cell Carcinoma and Correlates with ALK/EML4 Alteration.

Gerd Jomrich, Dagmar Kollmann, Winny Yan

|Sep 26, 2023
Systemic inflammatory biomarkers as prognostic tools in patients with gastroesophageal adenocarcinoma.

Hannah C Puhr, Clemens C Weirauch, Flora Selimi

Pageof 3

Frequent Collaborators

7 joint publications

Hannah Puhr

4 joint publications

Matthias Preusser

2 joint publications

Maximilian J Mair

2 joint publications

Anna Sophie Berghoff